Unknown

Dataset Information

0

Natural killer cells and cytotoxic T lymphocytes are required to clear solid tumor in a patient-derived xenograft.


ABSTRACT: Existing patient-derived xenograft (PDX) mouse models of solid tumors lack a fully tumor donor-matched, syngeneic, and functional immune system. We developed a model that overcomes these limitations by engrafting lymphopenic recipient mice with a fresh, undisrupted piece of solid tumor, whereby tumor-infiltrating lymphocytes (TILs) persisted in the recipient mice for several weeks. Successful tumor engraftment was achieved in 83% to 89% of TIL-PDX mice, and these were seen to harbor exhausted immuno-effector as well as functional immunoregulatory cells persisting for at least 6 months postengraftment. Combined treatment with interleukin-15 stimulation and immune checkpoint inhibition resulted in complete or partial tumor response in this model. Further, depletion of cytotoxic T lymphocytes and/or natural killer cells before combined immunotherapy revealed that both cell types were required for maximal tumor regression. Our TIL-PDX model provides a valuable resource for powerful mechanistic and therapeutic studies in solid tumors.

SUBMITTER: Le DT 

PROVIDER: S-EPMC8410059 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Natural killer cells and cytotoxic T lymphocytes are required to clear solid tumor in a patient-derived xenograft.

Le Duy Tri DT   Huynh Tridu R TR   Burt Bryan B   Van Buren George G   Abeynaike Shawn A SA   Zalfa Cristina C   Nikzad Rana R   Kheradmand Farrah F   Tyner John J JJ   Paust Silke S  

JCI insight 20210708 13


Existing patient-derived xenograft (PDX) mouse models of solid tumors lack a fully tumor donor-matched, syngeneic, and functional immune system. We developed a model that overcomes these limitations by engrafting lymphopenic recipient mice with a fresh, undisrupted piece of solid tumor, whereby tumor-infiltrating lymphocytes (TILs) persisted in the recipient mice for several weeks. Successful tumor engraftment was achieved in 83% to 89% of TIL-PDX mice, and these were seen to harbor exhausted im  ...[more]

Similar Datasets

| S-EPMC7188741 | biostudies-literature
| S-EPMC7684975 | biostudies-literature
| S-EPMC3769186 | biostudies-literature
| S-EPMC6700835 | biostudies-literature
| S-EPMC6041303 | biostudies-literature
| S-EPMC5934500 | biostudies-literature
| S-EPMC6474204 | biostudies-literature
| S-EPMC5650936 | biostudies-literature
| S-SCDT-10_15252-EMBR_202255681 | biostudies-other
| S-EPMC11875761 | biostudies-literature